Trial intelligence / Profile preview

Tenoxicam Efficacy by CYP2C9 Genotype in Third Molar Surgery

NCT04182191Phase 4Completed

Sponsor
Universidade de São Paulo
Start
Mar 2018
Primary completion
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tenoxicam in postoperative pain, sponsored by Universidade de São Paulo. Started Mar 2018; status: completed.

02

Drugs

tenoxicam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04182191.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04182191.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call